The National Institutes of Health (NIH) is offering the Innovative Research in Cancer Nanotechnology (IRCN) grant to drive transformative discoveries in cancer biology and oncology using nanotechnology. This grant is for projects addressing major cancer barriers by emphasizing mechanistic studies of nanomaterial and nanodevice interactions with biological systems. Proposed research can involve in vivo delivery of nanoparticles and nanodevices to cancer targets, or in vitro characterization of detection and diagnostic tools. The program seeks to generate fundamental knowledge crucial for informing and advancing the future development of nanotechnology-based cancer interventions.
Opportunity ID: 328661
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-20-284 |
Funding Opportunity Title: | Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 13, 2020 |
Last Updated Date: | Aug 13, 2020 |
Original Closing Date for Applications: | May 04, 2023 |
Current Closing Date for Applications: | May 04, 2023 |
Archive Date: | Jun 09, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) entitled “Innovative Research in Cancer Nanotechnology (IRCN)” encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-284.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 328661 Full Announcement-PAR-20-284 -> PAR-20-284-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00262991 | Oct 04, 2020 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269776 | Oct 28, 2021 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277715 | Nov 01, 2022 | May 04, 2023 | View |
Package 1
Mandatory forms
328661 RR_SF424_2_0-2.0.pdf
328661 PHS398_CoverPageSupplement_5_0-5.0.pdf
328661 RR_OtherProjectInfo_1_4-1.4.pdf
328661 PerformanceSite_2_0-2.0.pdf
328661 RR_KeyPersonExpanded_2_0-2.0.pdf
328661 PHS398_ResearchPlan_4_0-4.0.pdf
328661 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
328661 RR_Budget_1_4-1.4.pdf
328661 RR_SubawardBudget30_1_4-1.4.pdf
328661 PHS398_ModularBudget_1_2-1.2.pdf
328661 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
328661 RR_SF424_5_0-5.0.pdf
328661 PHS398_CoverPageSupplement_5_0-5.0.pdf
328661 RR_OtherProjectInfo_1_4-1.4.pdf
328661 PerformanceSite_4_0-4.0.pdf
328661 RR_KeyPersonExpanded_4_0-4.0.pdf
328661 PHS398_ResearchPlan_4_0-4.0.pdf
328661 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
328661 RR_Budget_3_0-3.0.pdf
328661 RR_SubawardBudget30_3_0-3.0.pdf
328661 PHS398_ModularBudget_1_2-1.2.pdf
328661 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
328661 RR_SF424_5_0-5.0.pdf
328661 PHS398_CoverPageSupplement_5_0-5.0.pdf
328661 RR_OtherProjectInfo_1_4-1.4.pdf
328661 PerformanceSite_4_0-4.0.pdf
328661 RR_KeyPersonExpanded_4_0-4.0.pdf
328661 PHS398_ResearchPlan_5_0-5.0.pdf
328661 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
328661 RR_Budget_3_0-3.0.pdf
328661 RR_SubawardBudget30_3_0-3.0.pdf
328661 PHS398_ModularBudget_1_2-1.2.pdf
328661 PHS_AssignmentRequestForm_3_0-3.0.pdf